Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

E-ISSN： 1873-4286|19|21|3816-3826

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.21, 2013-06, pp. : 3816-3826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients

By Di Minno Matteo Nicola Dario

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 9-23

Informa Healthcare

Access to resources Recommend Favorite

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 2055-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim Schott Gisela

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Guidelines for Stroke Prevention in Patients with Atrial Fibrillation

By Howard P.A.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 997-1009

Adis International

Access to resources Recommend Favorite

Relation of Low Vitamin D to Nonvalvular Persistent Atrial Fibrillation in Chinese Patients

By Chen Wei Ren Liu Zhi Ying Shi Yang Yin Da Wei Wang Hao Sha Yuan Chen Yun Dai

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 166-173

Blackwell Publishing

Access to resources Recommend Favorite